Dexcom Inc

Insider sale of 1,700 Dexcom shares by EVP Michael Jon Brown shows disciplined liquidity management—not a bearish signal; focus remains on product growth and buyback plans.

Dexcom insider sale: EVP Michael Brown sells 1,700 shares under 10(b)(5)(1) – a routine liquidity move that shouldn’t affect the stock’s growth outlook.

Dexcom insider activity: CFO’s RSU grant signals confidence in CGM growth and may temper recent price dips.